New-ATE-Logo2019

 

12-3-2020 Corning Speaker Image

Ben Josey, PhD
Field Applications Scientist
Corning Life Sciences

Opto-Sensor Guided Centrifugation for Efficient, Reagent-Free Cell Separation in a Semi-Automated Closed System

Dec. 3, 2020, at 11 am ET (8 am PT | 5 pm CET)

This Ask the Expert webinar will cover ways you can reduce the manual steps involved in traditional cell processing. This includes: Tips to streamline cell separation and formulation of specific cell populations for cell and gene therapy development and manufacturing and ways to reduce overall processing time while providing savings and increasing the yield and efficiency of high value samples.

register-now-button

 

crl-speaker2 crl-speaker1
Christopher Sucato, PhD, Associate Director, Biophysical Characterization, Charles River Laboratories; and Cynthia Swanson, Associate Research Scientist, Charles River Laboratories
 

Analytical Ultracentrifugation for
Characterization of AAV Gene Delivery Vectors

Dec. 8, 2020, at 11 am ET (8 am PT | 5 pm CET)

This webinar will discuss the new parameters of AUC analysis and how to maintain conformation to ICH guidelines. Learn how to bridge the gap from traditional methods to a high-quality AUC platform for your AAV program. We will also explore the Aiforia neural network (NN), which has been trained to recognize negatively stained AAV capsids in TEM images.


register-now-button

 

jason-sterling John-rockwell
Jason Sterling, Principal Scientist and Project Director, Analytical and Formulation Resources, Catalent Pharma Solutions; and John Rockwell, Group Leader, Catalent Pharma Solutions

Exploring New and Improved Analytical Methods for Traditional and Unique Modalities

Dec. 10, 2020, at 11 am ET (8 am PT | 5 pm CET)

This presentation will share the latest challenges in biophysical characterization and provide solutions to overcome these challenges, including:
  • A method to evaluate extractables and leachables in order to measure residual-free toxins during antibody–drug conjugate (ADC) development
  • Three common techniques (glycopeptide analysis, N-glycan analysis, and sialic acid analysis) that are used to identify, characterize, and quantitate sialic acids on biologics molecules
  • Additional drivers of new method development for biophysical characterization.

 

register-now-button

 

Yiyu Dong-1 David Barnard - 1
Yiyu Dong, Head of Cell Line Development, WuXi Advanced Therapies; and David Barnard,Senior Scientist, Process and Technology Development
WuXi Advanced Therapies

AAV Suspension Platform Generations:
Continuous Improvement Leading to
Increased Viral Vector Titer and Yield

Dec. 15, 2020, at 11 am ET (8 am PT | 5 pm CET)

WuXi Advanced Therapies launched a world-class AAV suspension platform early 2020. In this webinar, we will reveal the improvements that increased viral vector titer and yield on our platform.

register-now-button